The HFA Atrial Disease workshop is a joint initiative of HFA Committees on Co-morbidities, the Translational Research Committee, the Committee on Surveys, Registries and Epidemiology, Committee of HFPEF and the Committee on Cardiomyopathies of the Heart Failure Association.
Atrial Fibrillation and Heart Failure co-treatment
The atria play may a major role in the circulatory system and are affected by a number of conditions (valve disease, hypertension, heart failure, congenital disease, pulmonary hypertension, lung disease and atrial fibrillation/flutters syndromes). It is misleading to view Atrial Fibrillation as an isolated entity, independent of atrial function or the disorders that pre-dispose to it.
Atrial disorders are extremely common, cause untold morbidity and expense, they also complicate many disorders in cardiology and beyond. Yet no specialist society has codified Atrial disorders, an essential step towards increasing awareness, enhanced research and ultimately clinical practice advice for the betterment of patients and cost reduction for healthcare systems.
Prof. Frank RuschitzkaPresident of the Heart Failure Association
Prof. Petar SeferovicPresident-Elect of the Heart Failure Association
Prof. Andrew CoatsHFA Board memberChair of the Co-morbidities Committee
Prof. Rudolf de BoerHFA Board memberChair of the Basic Science section
Prof. Lars LundHFA Board memberChair of the Surveys, Registries and Epidemiology
Prof. Stephane HeymansHFA Board memberChair of the Translational Research Committee
Gathering more than 31 experts, this workshop will focus on Atrial Fibrillation and Heart Failure co-treatment with the aim to define and analyse the concept of Atrial Disease as a Heart Failure syndrome and to publish a paper entitled “Codifying atrial disease: pathophysiology, epidemiology and treatment” in the European Journal of Heart Failure.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved